Helping Interventional Cardiologists Reduce Exposure to Ionizing Radiation
Reduce Exposure

Helping Interventional Cardiologists Reduce Exposure to Ionizing Radiation

Michael Ragosta, M.D. at the University of Virginia Health System, understands that there are risks with working in a cath lab. Radiation exposure may not show its effects right away, but long-term impacts such as left-sided brain tumors and posterior subcapsular lens changes (a precursor to cataracts), as well as other health issues, have been found with high prevalence in cath lab personnel. To help protect their physicians and staff, UVA has invested in equipment designed to reduce radiation exposure in the lab, including the CorPath System. Click below to see why Dr. Ragosta chose the CorPath System for radiation safety and what his plans are with the system going forward.

READ MORE
Cath Lab Digest

Study Examining Inaccurate Lesion Length Measurements Published in Cath Lab Digest

In a study published in the June issue of Cath Lab Digest, Dr. Paul Campbell, Sanger Heart & Vascular Institute investigates the accuracy of lesion length measurements using visual estimation and the subsequent stent selection by interventional cardiologists. The study found that "eyeballing" is not an accurate method of lesion length measurement as over half of the lesions were estimated too short and approximately 20% were measured too long. In addition, five images were repeated and one-third of the time they were measured at a difference of 3mm or more. The study explores technologies to help solve the issue of inaccurate lesion length measurements, highlighting the CorPath System as a key tool in Dr. Campbell's own practice.

LEARN MORE
C3 Conference

CorPath System Robotically Deployed Bioresorbable Vascular Scaffold During Live Broadcast of a Complex Coronary Intervention at the 2015 C3 Conference

Recently, we announced that a complex percutaneous coronary intervention was broadcast live to attendees of the 2015 Complex Cardiovascular Catheter Therapeutics Conference in Orlando, Florida. Interventional cardiologists from around the world watched Arif Al Nooryani, MD, perform the triple-vessel disease case robotically in real-time by deploying bioresorbable stents, wiring the lesion and placing the stents using the CorPath System.

READ MORE
Spectrum Health

Why CorPath? Interview with Anne Beekman, Cath Lab Manager at Spectrum Health

Recently, we interviewed Anne Beekman, the Cath Lab Manager at Spectrum Health, about the factors that led to her investment in a CorPath System. Originally, Anne and her team were drawn to the CorPath by its procedural benefits, but found additional benefits when they visited another hospital that had implemented the technology. Seeing the reduction in radiation exposure and the elimination of lead aprons, that often leads to orthopedic strain, made the decision easy for Anne and her team. She also sees the potential to use the system as a recruiting tool for future employees, as physicians entering the field are far more aware of radiation risks, which will help make them more competitive. Spectrum Health recently purchased their second CorPath System to help increase physician access and to promote repetition to increase the technologist's skills. Click below to read Anne's full interview.

READ MORE
SD Interventions 2015
LEARN MORE
 
For more information on CorPath email: sales@corindus.com
Copyright Corindus, Inc.
309 Waverley Oaks Road, Suite 105, Waltham, MA 02452, US
Phone 800-605-9635 | Fax 508-653-3355
www.corindus.com | Contact us